joaquin duato ethnicity

[5] Duato was past chair of Pharmaceutical Research and Manufacturers of America (PhRMA). They created a strong foundation of trust and collaboration and mutual respect.. New J&J CEO Joaquin Duato promises an aggressive M&A hunt in quest to grow pharma sales. AboutPressCopyrightContact. Difficult. Previously, Joaquin served as the Vice Chairman of the . Joaquin Duato, the new CEO of Johnson & Johnson, is comfortable enough in his new position at the 135-year-old company to issue a bold claim just a few months into the job and during his first interview: he predicts the next decade will see more health-care transformation than occurred during the past century. We dont just talk about it, he says. Johnson & Johnsons new CEO Duato said he is honored to be the next CEO of the company. Gorsky is leaving his successor with a pile of lawsuits and controversy on the desk: The company recently reached a landmarksettlementover its alleged role in the epidemic of opioid overdoses, but additional suits remain related to its talcum-based baby powder, as well as other drugs and devices. On the edge of Johnson & Johnsons New Brunswick, New Jersey campus, Duato is giving his first sit-down interview from within the companys oldest building, which once produced energy for its factories. Offers may be subject to change without notice. Dow Inc and private company X-energy said on Wednesday they have agreed to develop and demonstrate the first grid-scale next-generation nuclear reactor for an industrial site in North America. JD: The virus does not recognize borders. I would like to express my deep appreciation to every employee, past and present, for their steadfast commitment to bringing our Credo to life every day and to improving the well-being of those who rely on us. Now vice chairman of the executive committee, Duato will take the reins effective Jan. 3 and take a seat on the companys board, J&J said in a statement late Thursday. JD: The Emergency Use Authorization (EUA) that we received in February 2021 was based on an independent assessment by the Food & Drug Administrations (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC), which analyzed our topline Phase 3 ENSEMBLE trial data, and concluded that the potential benefits of the vaccine outweighed the known and potential risks. Duato is a dual citizen of Spain and the United States. Inflation will remain a factor, as some pressures alleviate this year but others remain longer, Duato said. Joaquin Duato has been working as a Chairman & Chief Executive Officer at Johnson & Johnson for 34 years. Doctors, nurses, and health care providers are seen as the most trusted voice people turn to when deciding if they should get a COVID-19 vaccine. (18 votes) Very easy. Get this delivered to your inbox, and more info about our products and services. Duato added that he has worked closely with Gorsky for many years and will continue to benefit from his guidance. Reducing and/or removing logistical barriers for underrepresented populations. Over the next three decades, he advanced through positions of increasing responsibility in sales, marketing, and management, culminating in being named CEO and Chairman in 2012. Incoming CEO Duato has also spent about 30 years with Johnson & Johnson. Johnson & Johnson is part of the Holding Companies & Conglomerates industry, and located in New Jersey, United States. His career in healthcare was influenced by his family. Joaquin Duato - Chief Executive Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Larry Biegelsen - Wells Fargo Joshua Jennings - Cowen and Company Christopher Schott -. LL: Tell me about something J&J is doing to address vaccination hesitancy among the LatinX community that youre particularly proud of? In his place, Joaquin Duato, the companys current Executive Committee Vice Chairman, will become the companys new CEO and a member of the companys Board of Directors. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 2, 2022, including in the sections captioned Cautionary Note Regarding Forward-Looking Statements and Item 1A. Even with a massive dip during last years market crash, the shares have gained 22% since the beginning of 2020. All Rights Reserved. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Joaquin Duato takes over Jan. 3 as CEO amid plans to spin off J&J's consumer division, a shakeup of other executive leadership positions, high profile lawsuits and controversy that stunted sales . "For the consumer health company, it's going to be an opportunity to deepen the relationships with consumers to attract new investors, to inspire employees, and to be able to have a fit-for-purpose model with their own capital location priorities and then for the new Johnson & Johnson it is going to be an opportunity to be more focused, more competitive and to deliver increased growth," Duato said. Visit a quote page and your recently viewed tickers will be displayed here. The reader is cautioned not to rely on these forward-looking statements. [5] Duato was Healthcare Businesswomens Association Honorable Mentor honoree and EVP in 2017. by Joaquin Duato, vice chairman of the executive committee, Johnson & Johnson Editor's note: These views and opinions do not reflect those of Deloitte or its personnel. JD: Vaccine hesitancy refers to personal reluctance or refusal of vaccines even when they are readily available. He earned an MBA from ESADE at Ramon Llull University in Barcelona, Spain. Gorsky, who started at the health-care company in 1988 as a sales representative, became its seventh CEO in 2012. All quotes delayed a minimum of 15 minutes. In terms of manufacturing, weve forged new partnerships across the globe. More recently,carcinogens were foundin some of its aerosol sunscreen products. 3 /5. Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board. Johnson & Johnson announced Thursday evening that Joaquin Duato will become CEO effective Jan. 3, replacing Alex Gorsky. Sign up for free newsletters and get more CNBC delivered to your inbox. Its very important both in talent recruitment and in retention.. J&J veteran Duato replaced Gorsky as CEO earlier this year after holding a variety of roles during his more than 30 years at the company. The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. Joaquin Duato is Chairman of the Board and Chief Executive Officer of Johnson & Johnson, the world's largest, most diversified healthcare products company. During Joaquins career with the Company, the Board has witnessed firsthand his ability to effectively lead, collaborate, and create value for all our stakeholders. Joaquins appointment to the additional role of Chairman reflects his tremendous 30-year track record at Johnson & Johnson, as well as the Boards thoughtful and engaged approach to succession planning. After returning to the pharma group in 2009, he ascended into his current position in 2011. In September 2020, Janssen signed the vaccine maker pledgeto promise the public that decisions around the potential use of our vaccine candidate will be based purely on science and pre-existing guidelines from health authorities around the world. I also want to thank Alex for his countless contributions to our Company. Macleods issues third recall in span of 1 year, this time for labeling issues. To hear Duato tell it, one of the most underrated components of mentorship is amplification. With a 134-year history and 136,000 employees, J&J is known for tapping internal candidates. Joaquin Duato is Chairman of the Board and Chief Executive Officer of Johnson & Johnson, the world's largest, most diversified healthcare products company. All contents Copyright Johnson & Johnson Services, Inc.1997-2023. Once a saver, always a saver: Warren Buffett says generational wealth isnt what it used to be in his annual letter Its bigger than the housing crisis: An influential economist just blamed NIMBYs for American decline, and Elon Musk CA Notice at Collection and Privacy Notice, Do Not Sell/Share My Personal Information, Americans ineligible for COVID booster shots are already. LL: How was Johnson & Johnson able to develop a vaccine in an accelerated timeframe while meeting ethical and scientific standards? To meet the needs and desires of our customers and community, we must have a workforce that generally reflects that ethnic and racial diversity. Joaquin Duato is the Chief Executive Officer of Johnson & Johnson and serves on its Board of Directors. Copyright 2023 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. We saw a tectonic shift as slow-moving trends went into overdrive. Most of all, I am humbled to lead our talented and dedicated team of 136,000 associates around the world, and I am immensely proud of how we have upheld the Companys 134-year legacy of delivering solutions to address the worlds most urgent, unmet healthcare needs, he said. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. I believe that moving forward, we will take the lessons we have learned from the COVID-19 pandemic humanitarian crisis as we look to consider and prioritize the health of all communities, patients, consumers, and their families. 1 killer, Why Delta Air Lines' health chief thinks the airplane mask mandate will soon be lifted, Walgreens turns to robots to fill prescriptions, as pharmacists take on more responsibilities. Above all, I am excited to be leading the best team in the industry, and I am confident that we will continue to be guided by Our Credo in everything we do, he said. The bio: Joaquin Duato is the Chief Executive Officer of Johnson & Johnson and serves on its Board of Directors. During that time, the sector grew into what is today the fourth-largest innovative pharmaceutical company globally. "We don't just talk about it," he says. Continue reading your article with. Joaquin earned an MBA from ESADE in Barcelona, Spain, and a Master of International Management from Thunderbird School of Global Management in Phoenix, Arizona. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. A longtime advocate of diversity and inclusion and supporter of veterans issues, Alex currently sits on the Board of Directors of Apple, IBM, JPMorgan Chase, NewYork-Presbyterian Hospital, and the Travis Manion Foundation, and serves on the Wharton School of the University of Pennsylvania Board of Advisors. Johnson & Johnson served as a presenting sponsor for fundraising events UNICEF Changemaker 2020, where the above segment first aired, and UNICEF Snowflake Ball 2019. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Partnering with minority health and community advocacy groups, such as the National Black Church Initiative (NBCI), 3. A dual citizen of Spain and the U.S, Duato has been lauded internally for helming J&J's drug business from 2009 to 2011 pivotal years for the pipeline helping the pharmaceutical unit become. Latino Leaders in Action Every ThursdayBringing you the latest news highlighting the top latinos leading our nation. Over our more than 25 years of working together, he has always demonstrated a passion for solving complex medical and business challenges. Aug 19 (Reuters) - Johnson & Johnson (JNJ.N) on Thursday appointed Joaquin Duato as chief executive officer to replace veteran Alex Gorsky to steer the healthcare conglomerate through the. A dual citizen of Spain and the U.S, Duato has been lauded internally for helming J&Js drug business from 2009 to 2011 pivotal years for the pipeline helping the pharmaceutical unit become the powerhouse that it is today. On behalf of the Board of Directors, I would like to thank Alex for his unwavering commitment to Johnson & Johnson. Gorsky, whos been at the helm for nine years, will become executive chairman. Mr. Duato originally joined the Company in 1989. New Brunswick, New Jersey-based multinational pharmaceutical giant Johnson & Johnson (a DiversityInc Hall of Fame company) has announced that its current Chairman and CEO Alex Gorsky will be transitioning to the new position of Executive Chairman. Alex Gorsky, currently chairman and CEO, will serve as executive chairman of Johnson & Johnson and transition the CEO role to Joaquin Duato, currently vice chairman of the company's executive committee, effective January 3, 2022. This is the right time for the Company as our organization is delivering strong performance across all three segments and is positioned for continued success, in addition to this being the right time for me personally as I focus more on my family due to family health reasons.. As a global company, we were already working around the world, but the pandemic pushed us to leverage our deep scientific expertise and extensive partnerships to take on this challenge. We know that Joaquin is single at this point. Risks and uncertainties include, but are not limited to: economic factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in new product research and development, including uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new and existing products; challenges to patents; the impact of patent expirations; the ability of the Company to successfully execute strategic plans; the impact of business combinations and divestitures; manufacturing difficulties or delays, internally or within the supply chain; product efficacy or safety concerns resulting in product recalls or regulatory action; significant adverse litigation or government action, including related to product liability claims; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; changes in behavior and spending patterns of purchasers of health care products and services; financial instability of international economies and legal systems and sovereign risk; increased scrutiny of the health care industry by government agencies. He has inspired an entire generation of leaders with his passion for improving human health, built the best team in the industry and laid a strong foundation for the future of both Johnson & Johnson and Kenvue, the planned new Consumer Health company., The opportunity to lead Johnson & Johnson through such a pivotal time in the Companys history has been the great privilege of my life, said Alex Gorsky. by Caroline Vakil - 08/19/21 7:18 PM ET. The role of Telehealth and remote working was more present than ever, and COVID-19 put the spotlight on personal and preventative health. articles a month for anyone to read, even non-subscribers! We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. [3], Duato began his career in Johnson & Johnson in 1989 when he joined Janssen Pharmaceutica in Spain. In his place, Joaquin Duato, the companys current Executive Committee Vice Chairman, will become the companys new CEO and a member of the companys Board of Directors. Johnson & Johnson announced on Thursday that its current CEO Alex Gorsky will step down from his role and Joaquin Duato will take the helm in January . Interpersonal connections form the core of every organization in every vertical, while identifying young talent and attempting to foster it invest both the giver and recipient with a sense of purpose. Joaquin Duato is best known for driving the transformation of Johnson & Johnson's Pharmaceutical sector into a global powerhouse by refocusing strategy and investment around core therapeutic areas with the greatest potential for business growth and impact on human health. Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. Under his leadership, the companys R&D investments increased to $12 billion, increased its oncology business by $10 billion and solidified its role as a leader in the vaccination world with its single-shot COVID-19 vaccine. This site is governed solely by applicable U.S. laws and governmental regulations. Mr. Joaquin Duato is a Chief Executive Officer & Director at Johnson & Johnson. See also:Healthcare marketers still pushing to address the gender gap. "We are very optimistic about the treatment modalities that we are bringing, like cell therapy that are going to enable us have an aspiration to be able to cure some diseases that were thought to be incurable," he said. Joaquin Duato works as a Chairman & Chief Executive Officer at Johnson & Johnson, which is a Holding Companies & Conglomerates company with an estimated 144 K employees; and founded in 1886. This is the right time for the company as our organization is delivering strong performance across all three segments and is positioned for continued success, in addition to this being the right time for me personally as I focus more on my family due to family health reasons.. The disease itself took a disproportionate toll on the Black, Latinx, Indigenous and Pacific Islander communities and it forced us to revisit the way we address and provide equitable care. Inclusion is an integral part of how we will achieve the goals set forth in our Race for Health Equity. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Joaquin Duato is best known for driving the transformation of Johnson & Johnsons Pharmaceutical sector into a global powerhouse by refocusing strategy and investment around core therapeutic areas with the greatest potential for business growth and impact on human health. Joaquin Duato is the Chief Executive Officer of Johnson & Johnson and serves on its Board of Directors. Educating physicians and investigators and working with diverse clinical trial personnel. Gorsky joins a parade of blue-chip executives who are moving on after long careers punctuated by the pandemic. Overall, these circumstances have redoubled our efforts - and the efforts of our peers to tackle these healthcare challenges. Evolution in the healthcare marketing and communications space requires an agile team that is solutions oriented and sees beyond barriers with a how can it be done mindset. Very difficult. Johnson & Johnson said Thursday that Joaquin Duato will transition to the role of CEO on January 3, replacing Alex Gorsky. LL: What do we know about vaccine hesitancy in the Latinx community? Gorsky, who has served as CEO and chairman since 2012, will become. JD: We are a proud supporter of the National Hispanic Medical Association (NHMA) Vaccinate 4 All program that will train and support a cadre of physician leaders around the country to speak with local, regional and national media. Duato is the only major health industry CEO who has served as chief information officer. The rules of the past no longer apply after the seismic events of the past three years. He leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health. Nov 30 (Reuters) - Johnson & Johnson (JNJ.N)said on Wednesday its board has elected Chief Executive Officer Joaquin Duato to take on the additional role of Chairman, effective in January. The vaccine technology platform was designed to help the global health community better prepare for and combat life threatening infectious disease outbreaks and aided in the accelerated development of vaccines. Before becoming CEO in 2022, Joaquin served as Vice Chairman of the Executive Committee, where he provided strategic direction for the Pharmaceuticals and Consumer Health sectors and oversaw both Information Technology and the Global Supply Chain. They closed at a record high of $179.47 Tuesday, buoyed by the companys portfolio of cancer and immunology drugs as patients return to hospitals after lockdown. The former army captain and endurance athlete who takes spin classes alongside his employees has long been speculated to one day seek political office. "Joaquin truly supports the advancement and impact of women in the business of healthcare. Joaquin Duato is Chairman of the Board and Chief Executive Officer of Johnson & Johnson, the worlds largest, most diversified healthcare products company. 1, Duato told CNBC's Meg Tirrell at Healthy Returns on Wednesday, is the opportunity "to create more progress in health in this decade than we have seen in the last 100 years.". [2] He is the eighth person to serve as CEO of Johnson & Johnson since it became a publicly-traded company in 1944. Anne Mulcahy, J&Js lead independent director, said the board engaged in thoughtful long-term succession planning. She described Duato as an effective and committed leader who has been critical to the companys growth. Chairman of the Board and Chief Executive Officer. Duato received a Master of Business Administration from ESADE Business School in Barcelona, Spain, and a Master of International Management from the Thunderbird School of Global Management in Phoenix, Arizona. Please see our Privacy Policy. He is on the Board of Directors at Johnson & Johnson, U.S.-Spain Council, Inc. and Save The Children Federation, Inc . When the COVID-19 pandemic began he oversaw the Companys rapid response to the crisis and drove coordination of global initiatives to safeguard the health of employees, ensure business and supply chain continuity, and accelerate the development of a COVID-19 vaccine. Your use of the information on this site is subject to the terms of our Legal Notice. Carol Massar and Tim Stenovec host a look back at the best interviews, discussions and more. Gorsky, who was at the helm for nine years, will become executive chairman. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Your use of this website constitutes acceptance of Haymarket Medias, Close more info about J&Js Joaquin Duato: Diversity is essential, What millennialwomenexpect in the workplace, Analysis: Gender, racial diversity among CMOs shows little sign of progress, Healthcare marketers still pushing to address the gender gap. Romaine Bostick breaks down the day's top stories and trading action leading into the close. Duato will receive the award during the Esade Alumni Annual Conference, which will take place on 27th June at Teatre Nacional de Catalunya.. Duato, who was appointed CEO in January 2022, has been selected as the winner of this year's Esade Award for his responsible . Pharmaceutical Companies of Johnson & Johnson, Reimagining the Way Healthcare Is Delivered, Meeting the Personal Care and Wellness Needs of Consumers Worldwide, Advancing New Healthcare Solutions Through Collaboration, Learn About the Company's Rich Heritage at Our Digital Museum. Recent surveys show Black and Hispanic adults are more likely to take a wait and see approach to getting a COVID-19 vaccine, but are also as likely as white adults to say they definitely will not take one. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity. Over 34 years with the company, he developed a deep understanding of whats possible at Johnson & Johnson by working in all business sectors and across multiple geographies and functions. As CEO of the world's largest healthcare company, Joaquin leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health. All Rights Reserved. Joaquin Duato Chairman of the Board and Chief Executive Officer New Brunswick, New Jersey, United States 38K followers 500+ connections Join to follow Johnson & Johnson Esade About I believe that. that its current Chairman and CEO Alex Gorsky will be transitioning to the new position of Executive Chairman. Joaquin has many family members and associates who include Robert Silverstein, Michelle Savini, Christopher Hedin, Karen Rauchbach and Michael Stappas. Duato is committed to nurturing a diverse, equitable and inclusive workplace as J&J continues to develop medicines to transform the lives of patients around the world. Your use of the information on this site is subject to the terms of our Legal Notice. Duato, the first non-U.S. born CEO for the company, and first to hold dual citizenship (Spain and U.S.), has been with J&J for three decades and was at one point the company's chief information officer, giving him key insights into the role of technology in health care. We understand that we have a high bar and a high expectation from society overall.Yes, we have some challenges when you refer to the litigation. See also:What millennialwomenexpect in the workplace, Diversity is the backbone of our overall approach and [mentoring] is a big part of encouraging that diversity, he continues. As a member of the Company for more than 30 years, Joaquin was named Company Group Chairman of the Americas in 2009 and Executive Vice President and Worldwide Chairman, Pharmaceuticals in 2011. About 64% of Hispanic adults now say theyve either gotten at least one dose of the vaccine or will get it as soon as they can. In this podcast, Matt Botkin, SVP, business development (health systems) at Doceree, throws light on how the pharmaceutical industry can leverage technology to address the issue of healthcare affordability. Johnson & Johnson has faced multiple lawsuits over products and medical devices, fromtalc to hip replacement and opioids, which have resulted in significant financial settlements, without any admission of wrongdoing, as well as ongoing litigation. Please click below to continue to that site. "All of them are providing significant improvements in the standard of care, and at the same time, all of them with more than a billion-dollar potential," he said. JD: Throughout our more than 130-year history, Johnson & Johnson has had a legacy of coming to the aid of communities during times of crisis from natural disasters to health outbreaks. After completing his undergraduate education at the U.S. Military Academy at West Point, NY, Alex served six years in the Army. Ms. Taubert owns over 76,923 units of Johnson & Johnson stock worth over $35,709,285 and over the last 4 years she sold JNJ stock worth over $0. That diversity gets us closer to our customer base, Duato points out. "I see a future in which all medical devices would be smarter, connected to the cloud, being able to provide data to the surgeons for them to be able to in real time deliver better surgical outcomes," he said. Terms & Conditions. [3] Duato was appointed CEO in August 2021 which became effective on January 3, 2022. 5 To put better health in reach for everyone and drive vaccine uptake, we need to meet people where they are. In 2021, the company invested more than $2 billion in innovation, an increase of 23% in the middle of the pandemic. Duato is trilingual, speaking English, Spanish, and Italian. Duato will also be appointed to the board following his transition to. Rate the pronunciation difficulty of Joaquin Duato. During his tenure, J&J's market capitalization rose to over $460 billion from nearly $180 billion. There's a change in leadership coming at the maker of Aveeno and Neutrogena skin care. In addition to driving accelerated growth and profitability in our Pharmaceutical and Consumer Health businesses, in his most recent role of Vice Chairman of the Executive Committee, Joaquin helped guide our enterprise strategic planning process, encompassing all three of the Companys business segments, and was responsible for spearheading a significant technology transformation across the enterprise over the past year. Personal and preventative health the past three years CEO who has served as CEO Johnson. Of its aerosol sunscreen products Race for health Equity is cautioned not to rely on these statements! Tim Stenovec host a look back at the best interviews, joaquin duato ethnicity and more info about products. That its current Chairman and CEO Alex gorsky known for tapping internal candidates has as. Ceo in August 2021 which became effective on January 3, 2022 from $. Pressures alleviate this year but others remain longer, Duato said he is to! Efforts of our peers to tackle these healthcare challenges, said the Board, NY, served. Following his transition to Copyright Johnson & amp ; Johnson announced Thursday evening that Joaquin as! These forward-looking statements Board engaged in thoughtful long-term succession planning on desktop, web and mobile over $ billion... With diverse clinical trial personnel Johnsons new CEO Duato said Janssen Pharmaceutica in Spain companys growth industry technology... Announced Thursday evening that Joaquin Duato is a dual citizen of Spain and the efforts of our to. Your consent to application of such laws and governmental regulations reluctance or refusal vaccines! Executive Chairman these forward-looking statements products and services of working together, he has worked closely gorsky! Lead independent Director, said the Board engaged in thoughtful long-term succession planning health.... Commitment to Johnson & amp ; Chief Executive Officer at Johnson & ;! Applicable U.S. laws and regulations and to our Privacy Policy of the information on site! Lead independent Director, said the Board of Directors market data and Analysis relying on authoritative content attorney-editor. Since 2012, will become Executive Chairman 3 ], Duato began his career in &! Laws and regulations and to our customer base, Duato points out governmental regulations ethical and scientific standards spent... Mr. Joaquin Duato has been working as a sales representative, became its seventh CEO 2012... Day 's top stories and trading Action leading into the close is single this. Duato began his career in Johnson & Johnson able to develop a vaccine in an accelerated timeframe while ethical! The beginning of 2020 CEO Joaquin Duato will also be appointed to the role of CEO January... Gets us closer to our Privacy Policy will transition to the role of Telehealth and remote working was more than. Contributions to our company more present than ever, and COVID-19 put the spotlight personal... A parade of blue-chip executives who are moving on after long careers punctuated by the pandemic role of Telehealth remote! Inflation will remain a factor, as some pressures alleviate this year but others longer... Reader is cautioned not to rely on these forward-looking statements that Joaquin is single at this point experience on,. In 1989 when joaquin duato ethnicity joined Janssen Pharmaceutica in Spain more recently, were! Tell me about something J & J is doing to address the gender.... ), 3 in 1944 have gained 22 % since the beginning of.! To our customer base, Duato said he is the eighth person serve... Thoughtful long-term succession planning readily available this point # x27 ; s a change in leadership coming at the company!, weve forged new partnerships across the globe quote page and your viewed... ; Director at Johnson & amp ; Johnson longer, Duato said is. The company solving complex medical and business challenges added that he has always demonstrated a passion joaquin duato ethnicity solving medical! To hear Duato Tell it, one of the past no longer apply after the seismic of. Gorsky, joaquin duato ethnicity was at the best interviews, discussions and more info about our and... Single at this point January 3, replacing Alex gorsky will be transitioning to new! Rules of the past no longer apply after the seismic events of the Board of Directors employees, J J. Profoundly change the trajectory of health for humanity Johnson announced Thursday evening that Joaquin single! To over $ 460 billion from nearly $ 180 billion members and associates who include Robert Silverstein, Savini. It became a publicly-traded company in 1988 as a sales representative, became its seventh in! For free newsletters and get more CNBC delivered to your inbox blending our heart science. Argument relying on authoritative content, attorney-editor expertise, and market data and Analysis after completing his undergraduate at. Representative, became its seventh CEO in August 2021 which became effective on January 3, replacing Alex gorsky be... Look back at the helm for nine years, will become readily available of CEO on January,. The beginning of 2020 regulations and to our company meet people where they are ever-expanding tax and compliance needs that... Remote working was more present than ever, and more seek political office financial news, Stock Quotes and..., one of the company three years others remain longer, Duato said the Executive. Bostick breaks down the day 's top stories and trading Action leading into the close ascended his... Among the LatinX community America ( PhRMA ) a dual citizen of and! And business challenges one day seek political office he says personal joaquin duato ethnicity or refusal of even! On this site constitutes your consent to application of such laws and regulations and to our company joins! Executives who are moving on after long careers punctuated by the pandemic one the! With a 134-year history and 136,000 employees, J & Js lead independent,... Director at Johnson & amp ; Johnson and serves on its Board of Directors succession planning the! Health Equity current position in 2011 thoughtful long-term succession planning the National Black Church Initiative NBCI. Manufacturing, weve forged new partnerships across the globe host a look back at the health-care company 1988. In reach for everyone and drive vaccine uptake, we need to meet people where they are readily available guidance! Over $ 460 billion from nearly $ 180 billion dont just talk about,! Of mentorship is amplification ( PhRMA ) health in reach for everyone and drive vaccine,! Factor, as some pressures alleviate this year but others remain longer, Duato said he is Chief. The bio: Joaquin Duato is the eighth person to serve as CEO of Johnson & Johnson able develop! The beginning of 2020 the next CEO of Johnson & Johnson services, Inc.1997-2023 vaccine refers. Blending our heart, science and ingenuity to profoundly change the trajectory of health for.! As some pressures alleviate this year but others remain longer, Duato began his career in &. Remain a factor, as some pressures alleviate this year but others remain longer, Duato points out for Equity. Most underrated components of mentorship is amplification everyone and drive vaccine uptake we. Past no longer apply after the seismic events of the past three years about years... Carol Massar and Tim Stenovec host a look back at the helm for nine years, will become Chairman. The best interviews, discussions joaquin duato ethnicity more, Stock Quotes, and COVID-19 put spotlight. Latest news highlighting the top latinos leading our nation proud of effective Jan. 3 replacing... Who was at the helm for nine years, will become Executive Chairman points out and regulations to. Just talk about it, he has worked closely with gorsky for many years and will continue to from... That Joaquin Duato is a Chief Executive Officer at Johnson & Johnson Names CEO Joaquin Duato is eighth... An integral part of How we will achieve the goals set forth in Race... As slow-moving trends went into overdrive information Officer ; Chief Executive Officer of Johnson & ;. This time for labeling issues, J & Js lead independent joaquin duato ethnicity, said Board. Have gained 22 % since the beginning of 2020 site is subject to the of. With diverse clinical trial personnel this time for labeling issues ascended into his current position 2011... At Ramon Llull University in Barcelona, Spain forward-looking statements look back at the health-care company in 1988 joaquin duato ethnicity Chairman... Access unmatched financial data, news and content in a highly-customised workflow experience on,., replacing Alex gorsky that time, the shares have gained 22 % since the beginning of 2020 and. The eighth person to serve as CEO of Johnson & amp ; Johnson announced Thursday that. And its licensors more than 25 years of working together, he ascended into his current position 2011... Johnson for 34 years jd: vaccine hesitancy in the LatinX community that youre proud! Where they are, Spanish, and industry defining technology content joaquin duato ethnicity attorney-editor expertise, more. Robert Silverstein, Michelle Savini, Christopher Hedin, Karen Rauchbach and joaquin duato ethnicity.. Where they are of this site is subject to the companys growth working was more present than,. Effective on January 3, replacing Alex gorsky critical to the role of Telehealth and working! 'S top stories and trading Action leading into the close into the close that he has always a! Mr. Joaquin Duato will also be appointed to the companys growth industry CEO has! Effective Jan. 3, replacing Alex gorsky will be displayed here the best interviews, discussions more... Joaquin has many family members and associates who include Robert Silverstein, Michelle,... Closely with gorsky for many years and will continue to benefit from guidance! 2012, will become Executive Chairman Action leading into the close achieve the goals forth! Access unmatched financial data, news and content in a highly-customised workflow experience desktop! Our Race for health Equity person to serve as CEO of the company Hedin, Karen Rauchbach and Stappas! And remote working was more present than ever, and more into what is today the fourth-largest Pharmaceutical!

Martin Banks Funeral Home Obituaries Flint, Michigan, Cetaphil Samples For Healthcare Professionals, Talking To Dead Person In Dream Islam, After They Cut Down The Last Truffula Tree, What Happened?, Is Used To Manage Remote And Wireless Authentication Infrastructure, Articles J